These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22968139)

  • 21. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
    Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
    BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial.
    Bellad MB; Tara D; Ganachari MS; Mallapur MD; Goudar SS; Kodkany BS; Sloan NL; Derman R
    BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
    Al-Sawaf A; El-Mazny A; Shohayeb A
    J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial.
    Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO
    J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis.
    Sutherland T; Meyer C; Bishai DM; Geller S; Miller S
    Int J Gynaecol Obstet; 2010 Mar; 108(3):289-94. PubMed ID: 20079493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan.
    Smith JM; Dimiti A; Dwivedi V; Ochieng I; Dalaka M; Currie S; Luka EE; Rumunu J; Orero S; Mungia J; McKaig C
    Int J Gynaecol Obstet; 2014 Nov; 127(2):183-8. PubMed ID: 25051905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misoprostol in preventing postpartum hemorrhage: a meta-analysis.
    Langenbach C
    Int J Gynaecol Obstet; 2006 Jan; 92(1):10-8. PubMed ID: 16309682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
    Chatterjee S; Sarkar A; Rao KD
    PLoS One; 2016; 11(10):e0164718. PubMed ID: 27755601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal.
    Rajbhandari S; Hodgins S; Sanghvi H; McPherson R; Pradhan YV; Baqui AH;
    Int J Gynaecol Obstet; 2010 Mar; 108(3):282-8. PubMed ID: 20034628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia.
    Prata N; Gessessew A; Abraha AK; Holston M; Potts M
    Afr J Reprod Health; 2009 Jun; 13(2):87-95. PubMed ID: 20690252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research.
    Zvandasara P; Chipato T; Mawere E; Rivelt K; McNally T
    Cent Afr J Med; 2015; 61(9-12):76-83. PubMed ID: 29144067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advance misoprostol distribution for preventing and treating postpartum haemorrhage.
    Oladapo OT; Fawole B; Blum J; Abalos E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD009336. PubMed ID: 22336866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
    Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
    Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.
    Lubinga SJ; Atukunda EC; Wasswa-Ssalongo G; Babigumira JB
    PLoS One; 2015; 10(11):e0142550. PubMed ID: 26560140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual misoprostol for the prevention of postpartum hemorrhage.
    Al-Harazi AH; Frass KA
    Saudi Med J; 2009 Jul; 30(7):912-6. PubMed ID: 19618006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
    Chaudhuri P; Mandi S; Mazumdar A
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia.
    Sibley LM; Spangler SA; Barry D; Tesfaye S; Desta BF; Gobezayehu AG
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S73-82. PubMed ID: 24588919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misoprostol for postpartum hemorrhage: moving from evidence to practice.
    Starrs A; Winikoff B
    Int J Gynaecol Obstet; 2012 Jan; 116(1):1-3. PubMed ID: 22078140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal.
    Vlassoff M; Diallo A; Philbin J; Kost K; Bankole A
    Int J Gynaecol Obstet; 2016 Jun; 133(3):307-11. PubMed ID: 26952348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.